Provided by Tiger Trade Technology Pte. Ltd.

Janux Therapeutics, Inc.

14.16
+0.30002.16%
Post-market: 14.160.00000.00%16:20 EDT
Volume:1.03M
Turnover:14.50M
Market Cap:861.38M
PE:-7.72
High:14.29
Open:13.69
Low:13.60
Close:13.86
52wk High:35.34
52wk Low:12.12
Shares:60.83M
Float Shares:41.68M
Volume Ratio:1.03
T/O Rate:2.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8336
EPS(LYR):-1.8336
ROE:-11.48%
ROA:-9.55%
PB:0.90
PE(LYR):-7.72

Loading ...

Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2026

Major Issues Report

Form 8-K - Current report
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 19, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report